Search

Your search keyword '"Zeniya M"' showing total 219 results

Search Constraints

Start Over You searched for: Author "Zeniya M" Remove constraint Author: "Zeniya M"
219 results on '"Zeniya M"'

Search Results

1. Incidence and predictors of hepatocellular carcinoma in patients with autoimmune hepatitis

2. Incidence and predictors of hepatocellular carcinoma in patients with autoimmune hepatitis

3. Corrigendum to ‘An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs’ [J Hepatol 2021;75(3):572–581] (Journal of Hepatology (2021) 75(3) (572–581), (S0168827821003342), (10.1016/j.jhep.2021.04.055))

4. Systematic review of response criteria and endpoints in autoimmune hepatitis by the International Autoimmune Hepatitis Group

5. Corrigendum to ‘An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs’ [J Hepatol 2021;75(3):572–581] (Journal of Hepatology (2021) 75(3) (572–581), (S0168827821003342), (10.1016/j.jhep.2021.04.055))

6. X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis

7. An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs

8. Systematic review of response criteria and endpoints in autoimmune hepatitis by the International Autoimmune Hepatitis Group

9. X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis

15. International Autoimmune Hepatitis Group* Report: review of criteria for diagnosis of autoimmune hepatitis

16. Health-Related Quality of Life in patients with autoimmune hepatitis

22. PP060-MON: The Nutritional Relationship Between Nonalcoholic Fatty Liver Disease and Type 2 Diabetes

24. Validation of the Japanese version of the Fisk Fatigue Severity Score (FFSS) in Japanese patients with primary biliary cirrhosis

25. PP152-MON NUTRITIONAL ASSESSMENT OF PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS, OBSTRUCTIVE SLEEP APNEA, AND TYPE 2 DIABETES USING FOOD FREQUENCY QUESTIONNAIRES

28. 1305 POSITIVE ANTI-GP210 ANTIBODIES IS A RISK FACTOR FOR POOR BIOCHEMICAL RESPONSE TO URSODEOXYCHOLIC ACID TREATMENT IN JAPANESE PATIENTS WITH PRIMARY BILIARY CIRRHOSIS

30. 1109 POSITIVE ANTI-GP210 ANTIBODIES IS A STRONG RISK FACTOR FOR BILE DUCT LOSS AND HEPATITIS WHICH INDUCE JAUNDICE-TYPE PROGRESSION OF PRIMARY BILIARY CIRRHOSIS IN JAPANESE PATIENTS

34. Rapid decrease of plasma HCV RNA in early phase of twice daily administration of 3 MU doses interferon-beta in patients with genotype 1b hepatitis C infection: a multicenter randomized study.

38. Autoantibodies to hepatocyte plasma membrane antigens in autoimmune hepatitis: old and new subjects; what do we need?

39. X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis

40. An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs

41. Systematic review of response criteria and endpoints in autoimmune hepatitis by the International Autoimmune Hepatitis Group

45. Validation of the Japanese version of the Fisk Fatigue Severity Score (FFSS) in Japanese patients with primary biliary cirrhosis

46. Treatment challenges and investigational opportunities in autoimmune hepatitis

47. A genome-wide association study identified PTPN2 as a population-specific susceptibility gene locus for primary biliary cholangitis.

48. Autoimmune Hepatitis with Metabolic Dysfunction-associated Fatty Liver Disease.

49. Changes in lifestyle-related behaviour during the COVID-19 pandemic in Japan: a questionnaire survey for examinees who underwent an annual health check-up.

50. Relevance of leukaemia inhibitory factor to anti-melanoma differentiation-associated gene 5 antibody-positive interstitial lung disease.

Catalog

Books, media, physical & digital resources